{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04778",
    "Peptide Name": "Ll-CATH (L. liui cathelicidin, UCSS1a; natural AMPs; toad, amphibians, animals; likely 3S=S)",
    "Source": "the Chongâ€™an Moustache Toad,Leptobrachium liui, China, Asia",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "SRPCNCRCCYVARGNGRCLLRPGCFTVAARPNRSV",
    "Sequence Length": 35,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Chemotactic",
      "Anti-inflammatory"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Bridge",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 7,
    "Boman Index": 2.65,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "43%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Peptide discovery: predicted cathelicidin based on sequence alingment.Host expression: mainly expressed in spleen of the toad.Sequence analysis: APD analysis reveals that this sequence shows low similarity (38.1%) toPhD1R: 20%, C: 17%.Activity: Active against A.hydrophila ATCC7966 (MIC >100 ug/ml), E.coli K12 (MIC > 100 ug/ml), L.monocytogenes ATCC19115 (MIC >100 ug/ml), P. mirabilis ATCC25933 (MIC 100 ug/ml), S.enterica ATCC13076 (MIC > 100 ug/ml), S. epidermidis ATCC12228 (MIC 12.5 ug/ml), S.iniae ATCC29178 (MIC > 100 ug/ml), V. harveyi ATCC33866 (MIC 25 ug/ml), V. parahaemolyticus ATCC33847 (MIC 100 ug/ml), and V. vulnifcus ATCC279562 (MIC 3.75 ug/ml). I\n Anti-inflammatory: Ll-CATH treatment decreased TNF-alpha and il-1beta expression in RAW264.7 cells (only at high concentration, to be confirmed).",
    "Author": "Chen J, Zhang CY, Wang Y, Zhang L, Seah RWX, Ma L, Ding GH.2024",
    "Reference": "BMC Vet Res. 2024 Aug 2;20(1):343. doi: 10.1186/s12917-024-04202-9.PubMed",
    "Title": "Discovery of Ll-CATH: a novel cathelicidin from the Chong'an Moustache Toad (Leptobrachium liui) with antibacterial and immunomodulatory activity."
  },
  "3D Structure": []
}